+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07277231

Phase 3 Open-Label Randomized Trial Comparing Sonrotoclax Plus Zanubrutinib to Venetoclax Plus Acalabrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

Led by BeOne Medicines · Updated on 2026-09-28

500

Participants Needed

115

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of two fixed-duration drug combinations for adults with previously untreated chronic lymphocytic leukemia CLL. This Phase 3 study compares sonrotoclax plus zanubrutinib against venetoclax plus acalabrutinib to see which therapy better controls the disease. The trial is sponsored by BeOne Medicines and focuses on treatment outcomes in this patient group. Participants receive either sonrotoclax and zanubrutinib or venetoclax and acalabrutinib, both given orally for a set period. After completing the drug regimen, participants enter an observation phase to monitor their health and disease status. The study uses a randomized, parallel design without masking, meaning participants are assigned to one of two treatment groups openly. During the trial, participants undergo regular assessments including imaging to measure disease size, evaluations of bone marrow and organ function, and monitoring for side effects. The primary outcomes include progression-free survival monitored for up to about 70 months and rates of undetectable minimal residual disease measured up to approximately 16 months. Secondary outcomes cover response rates, overall survival, adverse events, and quality of life scores. The total study duration extends to late 2031, allowing long-term follow-up and safety evaluation.

CONDITIONS

Brief Title

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Research Team

S

Study Director

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here